Barbados received World Health Organization certification on 30 October 2026 for eliminating mother-to-child transmission of HIV as a public health problem. The decision followed an independent assessment of the country's prevention and care services, rather than a promise to improve them.

The most direct measure is what did not happen: WHO says there were no reported new HIV infections caused by mother-to-child transmission among infants born in Barbados from 2022 through 2024. Barbados Today reported, citing senior public health official Dr Dale Babb at the certification ceremony, that 6,352 live births were registered during those three years.

Years of care behind the result

Prevention depends on finding HIV infections during pregnancy, providing antiretroviral medicines and following up with babies who may have been exposed. According to WHO's assessment, 98% of pregnant women received antenatal care, 98% were tested for HIV, and 98% of pregnant women living with HIV received antiretroviral treatment during 2022–2024.

Barbados provides HIV testing and treatment free of charge to pregnant women regardless of nationality. Testing is voluntary and confidential. WHO says the assessment found no evidence of coercive reproductive health practices involving women living with HIV.

Local reporting also traces the long effort behind certification. Barbados began its mother-to-child transmission prevention programme in 1995. This is a result of sustained health services, not a single recent intervention.

What certification does, and does not, mean

The recognition is specific to mother-to-child transmission of HIV as a public health problem. It does not mean HIV itself has been eradicated from Barbados, that an individual transmission can never occur, or that prevention services are no longer needed.

WHO identifies continued investment, stronger health information systems, updated guidance, more HIV-syphilis testing and follow-up care as necessary to keep the achievement. The country's result shows what sustained access to prenatal testing and treatment can accomplish, while making continued access central to what comes next.